ASTA decided to utilize MALDI-TOF MS, which has received a Nobel prize for its importance in high molecule analysis. We have decided that MALDITOF technology is a better candidate for replacing the traditional diagnosis techniques. Therefore, we have been participating in research and development to develop such core technology for the past ten years, and with the support from the Korean government, we have managed to develop and commercialize various novel products such as next-generation diagnostics system and platform, sample plates, and diagnostics software in 2014.
Also known as: ASTA Corporation, ASTA, Inc.